Pneumococcal vaccination in splenectomised cancer patients

Clicks: 361
ID: 112870
2005
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #11 of 24 articles by views in European journal of cancer (Oxford, England : 1990)

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Although pneumococcal vaccination has been recommended in splenectomised patients for more than 30 years, its use remains unsatisfactory. We conducted two consecutive retrospective assessments to determine the rate of pneumococcal vaccination among splenectomised cancer patients at a single institut …
Reference Key
ag2005europeanpneumococcal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Omlin AG;Mühlemann K;Fey MF;Pabst T;;
Journal European journal of cancer (Oxford, England : 1990)
Year 2005
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/16026979
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine adult female male aged middle aged 80 and over neoplasms / complications* pneumococcal infections / prevention & control* pmid:16026979 doi:10.1016/j.ejca.2005.04.027 aurelius g omlin kathrin mühlemann thomas pabst hodgkin disease / complications pneumococcal vaccines* splenectomy / adverse effects*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.